Modulation of the immunogenic potential of cancer cells has already been demonstrated with cisplatin (CDDP) that as a single agent does not promote endoplasmic reticulum stress and therefore no translocation of calreticulin to the cell surface31. This evidence concerns the gene CALR and cancer.